Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Endologix AFX Graft System Should Not Be Used For Abdominal Aortic Aneurysms Due To Endoleaks: FDA This is the latest in a string of stent graft system warnings by the FDA, due to the risk of potentially fatal endoleaks. January 17, 2022 Russell Maas Add Your Comments Following reports of endovascular grafts causing severe bleeding problems, federal health officials are warning about problems with the Endologix AFX Graft system, recommending that patients with certain aortic endovascular graft systems receive annual checkups for the rest of their lives, and urging doctors to consider alternative treatment methods. The FDA issued an updated Endologix AFX Endovascular AAA Graft Systems (AFX2) safety communication on January 13, instructing patients and healthcare providers to continuously monitor and have endovascular grafts checked annually to prevent possibly fatal Type III endoleaks, which can lead to the need for additional surgeries and pose increased health risks to patients. Endovascular grafts are minimally invasive alternatives to open surgical repair for the treatment of abdominal aortic aneurysms, which may have a high risk of injury and death. While endovascular grafts typically carry fewer such risks, the health officials are urging doctors to consider the potential problems with Endologix AFX Grafts when weighing treatment alternatives. Tthe FDA has found Endologix AFX endovascular grafts carry risks of Type III endoleaks, in which blood flows into the abdominal aortic aneurysm, causing pressure to build up in the aneurysm sac, which could cause it to rupture. Patients who experience a rupture of the aneurysm sac require immediate medical intervention that may include re-lining, insertion of additional graft components, or open surgical repair that could increase the risk of morbidity. In many cases, such a rupture can be lethal. According to the safety communication, the Circulatory System Devices Panel of the FDA’s Medical Devices Advisory Committee recommended that AFX2 endovascular grafts should not be used for routine AAA treatment due to the increased risk of Type III endoleaks. While most members of the committee advocated the availability of the AFX2 devices should remain for select populations of patients, the FDA’s analysis and advisory committee recommends healthcare professionals to “consider using available alternative treatment options for AAA patients rather than the AFX2 device”. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA is also recommending that Endologix take additional steps to work with the agency to identify patients who may benefit from treatment with the AFX2 device and to update the device labeling, as well as identifying factors that could put patients at increased risk of Type III endoleak risks. Patients who have undergone implantation of an AFX with Strata, AFX with Duraply or AFX2 endovascular graft should be closely monitored and evaluated for Type III endoleaks, receiving at least yearly, lifelong imaging follow-ups with their primary healthcare provider, according to the FDA. Endovascular Grafts Health Risks A growing number of endoleak injuries caused by endovascular grafts have been reported in the last several years, prompting FDA officials to issue multiple stent graft warnings related to Endologix and Medtronic products. In April 2021, a Valiant Navion Thoracic Stent Graft System recall was issued by Medtronic following at least 11 reports of the devices failing, resulting in at least one patient death. Medtronic indicated they have become aware patients can experience stent fractures, the stent ring expanding beyond design specification, and endoleaks due to holes in the fabric which, if not detected and left untreated, may cause life-threatening bleeding events. In December 2020, the FDA released a similar Endologix AFX Endovascular AAA Graft Systems warning, finding the occurrence of Type III endoleaks in patients receiving AFX endovascular grafts with Duraply graft material may be higher than expected. As a result of continuous case reports of Type III endoleaks, the FDA announced it will continue to collect additional postmarket data to better understand the risk of Type III endoleaks for AFX endovascular grafts. In 2018, the FDA released an update suggesting the Endologix AFX with Stratus device carries a greater risk for causing Type III endoleaks when compared to other endovascular graft systems, finding the occurrence rate of Type III endoleaks for the AFX with Strata are 0.90 percent at two years and 5.0 percent at five years. The agency recommended medical professionals closely monitor patients who have previously undergone implantation with the AFX with Stratus devices, and consider how Type III endoleaks will impact patients during different stages of diagnosis. Officials are advising medical professionals also discuss all available treatment options to address endoleaks, including the risks and benefits of each. Tags: Aortic Aneurysm, Bleeding, Endoleak, Endovascular Graft System More Lawsuit Stories Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” July 3, 2025 Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL July 3, 2025 JAK Inhibitors Could Increase Cancer Risks by as Much as 40%: Study July 3, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 2 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 2 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 3 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 2 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 2 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 3 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)